Get started
Author

Xiaolei Shi

Oxidation of Alpha-Ketoglutarate Is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial Defects
2014 · Andrew R. Mullen, Zeping Hu, et al. · Cell Reports · 337
PDF
Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
2018 · Fang Huang, Min Ni, et al. · Cell Metabolism · 190
PDF
Regulation of branched-chain amino acid metabolism by hypoxia-inducible factor in glioblastoma
2020 · Bo Zhang, Yan Chen, et al. · Cellular and Molecular Life Sciences · 131
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
2014 · Ming Zeng, Zeping Hu, et al. · Science · 112
The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts
2017 · Xiaolei Shi, Alpaslan Tasdogan, et al. · Science Advances · 47
Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma
2022 · Zheng-yi Zhu, Ning Tang, et al. · Frontiers in Immunology · 30
PDF
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2023 · Justin Hwang, Xiaolei Shi, et al. · Clinical Cancer Research · 14
PDF
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer
2025 · Xiaolei Shi, Jarey H. Wang, et al. · Prostate Cancer and Prostatic Diseases · 2
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al. · Clinical Cancer Research · 1
Abstract B031: Proteomic profiling of oligometastatic castration-sensitive prostate cancer treated with stereotactic ablative radiotherapy
2025 · Jarey H. Wang, Amol Shetty, et al. · Clinical Cancer Research · 1
Identifying metabolomic features that predict metastasis of melanoma from a primary site
2014 · Xiaolei Shi, Zeping Hu, et al. · Cancer & Metabolism · 1
PDF
Multi-institutional Patient-level Comparison of Decipher Genomic Classifier and Artera Multimodal Artificial Intelligence (MMAI) in Prostate Cancer
2026 · Boon Hao Hong, Adeniyi A. Olabumuyi, et al. · Clinical Cancer Research
Data from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
Supplemental Tables 2-10 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
Supplemental Table 1 from B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
2026 · Allison Makovec, Ava P. Gustafson, et al.
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial
2026 · Xiaolei Shi, Amol C. Shetty, et al. · JCO Precision Oncology
Supplementary Figure 3 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Supplementary Table 2 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Supplementary Figure 2 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Supplementary Figure 1 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Supplementary Table 1 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Supplementary Table 3 from Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
2025 · Justin Hwang, Xiaolei Shi, et al.
Prognostic validation of six androgen production, uptake, and conversion genes (APUC-6) in the CHAARTED prostate cancer trial.
2025 · Xiaolei Shi, Amol Shetty, et al. · Journal of Clinical Oncology
Evaluating associations between genomic classifier and digital pathology–based multi-modal AI biomarkers in oligometastatic castration-sensitive prostate cancer.
2025 · Philip Anthony Sutera, Yang Song, et al. · Journal of Clinical Oncology
PDF
Abstract P008: Evaluating associations between genomic classifier and digital pathology based mutli-modal AI biomarkers in oligometastatic castration-sensitive prostate cancer
2025 · Philip A. Sutera, Yang Song, et al. · Clinical Cancer Research
Works count: 65
Citation count: 865
H-index: 7
I10-index: 7
Year
Topic
Type